Holen Sie sich die Stockscreener-App
0.16
54.29%
-0.19
Handel nachbörslich:
.15
-0.01
-6.25%
Schlusskurs vom Vortag:
$0.35
Offen:
$0.15
24-Stunden-Volumen:
8.41M
Relative Volume:
0.60
Marktkapitalisierung:
$1.05M
Einnahmen:
$23.48M
Nettoeinkommen (Verlust:
$-15.63M
KGV:
-0.0129
EPS:
-12.45
Netto-Cashflow:
$-23.92M
1W Leistung:
-60.00%
1M Leistung:
-58.76%
6M Leistung:
-86.55%
1J Leistung:
-95.79%
1-Tages-Spanne:
$0.135
$0.1849
1-Wochen-Bereich:
$0.135
$0.399
52-Wochen-Spanne:
$0.135
$4.12
Molecular Templates Inc Stock (MTEM) Company Profile
Firmenname
Molecular Templates Inc
Sektor
Branche
Telefon
512 896 1555
Adresse
9301 AMBERGLEN BLVD, AUSTIN, TX
Vergleichen Sie MTEM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTEM
Molecular Templates Inc
|
0.16 | 1.05M | 23.48M | -15.63M | -23.92M | -2.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Molecular Templates Inc Stock (MTEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-21 | Eingeleitet | BofA Securities | Buy |
| 2021-02-01 | Eingeleitet | UBS | Neutral |
| 2020-09-08 | Eingeleitet | Jefferies | Buy |
| 2020-03-25 | Eingeleitet | Stifel | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-04-29 | Eingeleitet | UBS | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-10-08 | Eingeleitet | Laidlaw | Buy |
Alle ansehen
Molecular Templates Inc Aktie (MTEM) Neueste Nachrichten
MTEM stock touches 52-week low at $0.15 amid sharp annual decline - Investing.com
Molecular Templates faces Nasdaq delisting By Investing.com - Investing.com Canada
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.18% - Investing.com
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Why Molecular Templates (MTEM) Stock Is Down 60% - Benzinga
MTEM stock touches 52-week low at $0.15 amid sharp annual decline By Investing.com - Investing.com South Africa
Molecular Templates faces Nasdaq delisting - Investing.com
Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules - The Manila Times
Molecular Templates Faces Nasdaq Delisting After Multiple Compliance Failures - StockTitan
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Inkl
Dyne Therapeutics (DYN) Stock Drops Amidst Biotech Sector Moveme - GuruFocus.com
Artelo Biosciences (ARTL) Stock Surges 5% Amid Strong Buy Ratings - GuruFocus.com
Stock market news: Molecular Templates increased by 60.83% while Algorhythm Holdings dipped by 47.40% during mid day trading - Business Upturn
Molecular Templates Announces Key Leadership Transition - TipRanks
Molecular Templates, Inc. Announces Executive Changes - Marketscreener.com
Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements - Marketscreener.com
Molecular Templates Faces Dual Nasdaq Compliance Warnings Over Filing, Stock Price - StockTitan
Stock Region Signal Report - substack.com
Molecular Templates faces delisting, seeks stockholder approval for dissolution - Investing.com India
Molecular Templates faces delisting, seeks stockholder approval for dissolution By Investing.com - Investing.com Australia
Compugen (CGEN) Stock Dips Amidst Biotech Sector Movements - GuruFocus.com
Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN
United States shares lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN
BB Biotech AG's Strategic Acquisition in Molecular Templates Inc - GuruFocus.com
Alphabet Cl A (GOOGL-Q) QuotePress Release - The Globe and Mail
Bb Biotech sells $845,833 in Molecular Templates shares - Investing.com India
Bb Biotech sells $845,833 in Molecular Templates shares By Investing.com - Investing.com UK
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT)’s Stock Reduces -12.58%, Making It A Good Investment - Stocks Register
Analysts Predict Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) To Loss -577.97% From Current Levels. - Stocks Register
Molecular Templates Inc (NASDAQ: MTEM) Drops -23.41 Percent In Recent Session, Why Are You Interested? - Stocks Register
Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
HALO Stock Dips 5.77% Amid Biotech Sector Changes - GuruFocus.com
Agenus (AGEN) Stock Dips Amid Financial Performance and Industry Trends - GuruFocus.com
U.S. STOCKS Talen Energy, Biogen, Ovintiv - XM
U.S. Stock market: Molecular Templates surges by 155.81% while Sow Good declines by 53.39% during mid day trading - Business Upturn
Austin InnoProper Good heads to the big box | Austin startups on the Deloitte Fast 500 - The Business Journals
Clairity Appoints Jeffrey R. Luber CEO as Firm Prepares for Global Expansion - cnhinews.com
Clairity Appoints Jeffrey R. Luber as CEO - citybiz
Finanzdaten der Molecular Templates Inc-Aktie (MTEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Molecular Templates Inc-Aktie (MTEM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BIOTECH TARGET N V | 10% Owner |
Apr 02 '24 |
Buy |
2.35 |
250,000 |
587,500 |
1,279,820 |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):